SCHEMBL7866698

SCHEMBL7866698

CC1Cc2cc(Cl)ccc2NC1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 2/20 0.53
SRD5A1 P18405 4/20 0.43
PGR P06401 1/20 0.42
RIPK1 Q13546 1/20 0.42
HTR2C P28335 4/20 0.41
HTR5A P47898 3/20 0.41
HTR2A P28223 3/20 0.41
HTR2B P41595 3/20 0.41
DRD4 P21917 3/20 0.41
ADRA2A P08913 2/20 0.41
ADRA2B P18089 2/20 0.41
ADRA2C P18825 2/20 0.41
HTR1D P28221 2/20 0.41
HTR7 P34969 2/20 0.41
HTR3A P46098 2/20 0.41
CMA1 P23946 1/20 0.41
TGM2 P21980 1/20 0.39
CES1 P23141 1/20 0.39
DRD2 P14416 1/20 0.39
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18743294 0.81 ACHE (0.49) HTR5A
SCHEMBL434007 0.81 ACHE (0.49) HTR5A
SCHEMBL14550603 0.80 BRD4 (0.51) AHRRIPK1HTR2CHTR2AHTR2B
SCHEMBL7428693 0.80 BRD4 (0.51) AHRRIPK1HTR2CHTR2AHTR2B
SCHEMBL14721601 0.80 CA9 (0.40) MEN1KMT2A
SCHEMBL1185925 0.78 CES1 (0.47) AHRPGRCMA1TGM2CES1
SCHEMBL20870384 0.78 PARP1 (0.40) HTR2CHTR2AHTR2BDRD4DRD2
SCHEMBL26443812 0.78 KIF11 (0.42) MEN1KMT2A
SCHEMBL20582071 0.78 AHR (0.54) AHRPGRRIPK1HTR2CHTR5A
SCHEMBL6363356 0.77 KCNJ1 (0.35) PGRHTR2CHTR2AHTR2BDRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024042494-A1 SUBSTITUTED PYRROLOTRIAZINES MOLECURE SA (PL) 2024-02-29 WO disclosed
EP-1069897-A1 METHODS FOR INHIBITING MRP1 ELI LILLY AND COMPANY (US) 2001-01-24 EP disclosed
WO-1999051227-A1 METHODS FOR INHIBITING MRP1 ELI LILLY AND COMPANY (US) 1999-10-14 WO disclosed